If you hate needles or want something FDA-approved specifically for obesity, Contrave holds its ground
Individuals with associated conditions like type 2 diabetes, high blood pressure, or high cholesterol may particularly benefit
Light carbohydrates like whole grains or fruits can also help fuel your body without overwhelming your digestive system
Maintaining weight loss after GLP1 treatment requires more than medication alone
Natalie Hernandez is a pediatric endocrinologist with advanced fellowship training in pediatric obesity medicine, metabolism, diabetes, and hormone health
Most incretin weight-loss therapies are injected subcutaneously, but oral semaglutide is already licensed in the UK for T2DM as Rybelsus, while its manufacturer Novo Nordisk has published positive phase III results (OASIS-4, NCT05564117) for its 25mg semaglutide pill for weight loss 6